F510-0194 Screening compound: 4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-6-(piperidine-1-carbonyl)-3,4-dihydro-2H-1,4-benzothiazin-3-one

F510-0194 Screening compound: 4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-6-(piperidine-1-carbonyl)-3,4-dihydro-2H-1,4-benzothiazin-3-one
F510-0194 Screening compound: 4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-6-(piperidine-1-carbonyl)-3,4-dihydro-2H-1,4-benzothiazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F510-0194
4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-6-(piperidine-1-carbonyl)-3,4-dihydro-2H-1,4-benzothiazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F510-0194

Molecular Formula

C26H30N4O3S (C26 H30 N4 O3 S)

Compound Name

4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-6-(piperidine-1-carbonyl)-3,4-dihydro-2H-1,4-benzothiazin-3-one

IUPAC name

4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-6-(piperidine-1-carbonyl)-34-dihydro-2H-14-benzothiazin-3-one

SMILES

O=C(CN1c(cc(cc2)C(N3CCCCC3)=O)c2SCC1=O)N(CC1)CCN1c1ccccc1

InChI

InChI=1S/C26H30N4O3S/c31-24(28-15-13-27(14-16-28)21-7-3-1-4-8-21)18-30-22-17-20(9-10-23(22)34-19-25(30)32)26(33)29-11-5-2-6-12-29/h1,3-4,7-10,17H,2,5-6,11-16,18-19H2

InChI Key

DNMHHPDSYDJQAK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27134820

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.62

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.270

Distribution Coefficient, logD

2.270

Water Solubility, LogSw

-2.80

Polar Surface Area

51.920

Acid Dissociation Constant (pKa)

20.50

Base Dissociation Constant (pKb)

3.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

F510-0194 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F510-0194 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F510-0194?
Check Price and Availability of F510-0194, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F510-0194 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F510-0194
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F510-0194
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F510-0194 available by request